Skip to main content
Erschienen in: Acta Neurologica Belgica 2/2014

01.06.2014 | Letter to the Editor

DVT and pulmonary embolism with stroke

verfasst von: Joseph R. Shiber

Erschienen in: Acta Neurologica Belgica | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Excerpt

An 86-year-old woman tripped over her dog fracturing her right femur and left ankle; she had operative repair of her femur but conservative treatment with immobilization of the ankle injury and received 6 weeks of subcutaneous heparin for prevention of deep venous thrombosis (DVT). One week later she noticed soreness in her right thigh and became acutely dyspneic when walking to the bathroom. On arrival at the hospital she was tachycardic and tachypneic, requiring high-flow oxygen to maintain her oxygen saturation above 90 %. Bilateral proximal pulmonary emboli (PE) were diagnosed by chest CT angiography (Fig. 1) and a heparin infusion was started. A transthoracic echocardiogram (TTE) demonstrated right ventricular dilation with leftward bowing of the interventricular septum, moderate-severe tricuspid regurgitation, and elevated pulmonary artery pressures. Based on these findings, tissue plasminogen activator (TPA) was given intravenously since no contraindications were present. Additionally, duplex ultrasonography found she had DVT of her right femoral and left popliteal veins.
Literatur
1.
2.
Zurück zum Zitat Mattle HP, Meier B, Nedeltchev K (2010) Prevention of stroke in patients with patent foramen ovale. Int J Stroke 5:92–102PubMedCrossRef Mattle HP, Meier B, Nedeltchev K (2010) Prevention of stroke in patients with patent foramen ovale. Int J Stroke 5:92–102PubMedCrossRef
3.
Zurück zum Zitat Handke M, Harloff A, Bode C, Geibel A (2009) Patent foramen ovale and cryptogenic stroke: a matter of age? Semin Thromb Hemost 35:505–514PubMedCrossRef Handke M, Harloff A, Bode C, Geibel A (2009) Patent foramen ovale and cryptogenic stroke: a matter of age? Semin Thromb Hemost 35:505–514PubMedCrossRef
4.
Zurück zum Zitat Handke M, Harloff A, Olschewski M et al (2007) Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 357:2262–2268PubMedCrossRef Handke M, Harloff A, Olschewski M et al (2007) Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 357:2262–2268PubMedCrossRef
5.
Zurück zum Zitat Tanislav C, Puille M, Pabst W et al (2011) High frequency of silent pulmonary embolism in patients with cryptogenic stroke and patent foramen ovale. Stroke 42:822–824PubMedCrossRef Tanislav C, Puille M, Pabst W et al (2011) High frequency of silent pulmonary embolism in patients with cryptogenic stroke and patent foramen ovale. Stroke 42:822–824PubMedCrossRef
8.
9.
10.
Zurück zum Zitat Irwin B, Ray S (2012) Patent foramen ovale–assessment and treatment. Cardiovasc Ther 30:e128–e135PubMedCrossRef Irwin B, Ray S (2012) Patent foramen ovale–assessment and treatment. Cardiovasc Ther 30:e128–e135PubMedCrossRef
11.
Zurück zum Zitat Schneeweiss S, Gagne JJ, Patrick AR et al (2012) Comparative efficacy and safety of new anticoagulants in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes 5:480–486PubMedCentralPubMedCrossRef Schneeweiss S, Gagne JJ, Patrick AR et al (2012) Comparative efficacy and safety of new anticoagulants in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes 5:480–486PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat O’Dell KM, Igawa D, Hsin J (2012) New anticoagulants for atrial fibrillation: a review of clinical trials. Clin Ther 34:894–901PubMedCrossRef O’Dell KM, Igawa D, Hsin J (2012) New anticoagulants for atrial fibrillation: a review of clinical trials. Clin Ther 34:894–901PubMedCrossRef
13.
Zurück zum Zitat Deedwania PC, Huang GW (2011) Role of emerging antithrombotic therapy in the prevention of cardioembolic complication in patients with atrial fibrillation. Am J Cardiovasc Drugs 11:265–275PubMedCrossRef Deedwania PC, Huang GW (2011) Role of emerging antithrombotic therapy in the prevention of cardioembolic complication in patients with atrial fibrillation. Am J Cardiovasc Drugs 11:265–275PubMedCrossRef
14.
Zurück zum Zitat Miller CS, Grandi SM, Shimony A et al (2012) Meta-analysis of efficacy and safety of new anticoagulants versus warfarin in patients with atrial fibrillation. Am J Cardiol 110(3):453–460PubMedCrossRef Miller CS, Grandi SM, Shimony A et al (2012) Meta-analysis of efficacy and safety of new anticoagulants versus warfarin in patients with atrial fibrillation. Am J Cardiol 110(3):453–460PubMedCrossRef
15.
Zurück zum Zitat Furlan AJ, Reisman M, Massarom J et al (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366:991–999PubMedCrossRef Furlan AJ, Reisman M, Massarom J et al (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366:991–999PubMedCrossRef
16.
Zurück zum Zitat Carroll JD, Saver JL, Thaler DE et al (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 368:1092–1100PubMedCrossRef Carroll JD, Saver JL, Thaler DE et al (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 368:1092–1100PubMedCrossRef
Metadaten
Titel
DVT and pulmonary embolism with stroke
verfasst von
Joseph R. Shiber
Publikationsdatum
01.06.2014
Verlag
Springer Milan
Erschienen in
Acta Neurologica Belgica / Ausgabe 2/2014
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-013-0205-7

Weitere Artikel der Ausgabe 2/2014

Acta Neurologica Belgica 2/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.